Klein and Associates, MD, PA

Cumberland, Maryland 21502

0 studies enrolling now · 17 studies all time

What they study most

Ankylosing Spondyloarthritis, Arthritis, Rheumatoid, Axial Spondyloarthritis, Chronic Gout, Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Spondyloarthritis

Studies at this site

• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) — Completed
• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis — Completed
• Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed
• A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis — Completed
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
• Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe — Completed
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed
• Methotrexate-Inadequate Response Study — Completed
• Phase IIIB Subcutaneous Missed Dose Study — Completed
• Abatacept Versus Adalimumab Head-to-Head — Completed